Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 21, 2017 08:30 ET | Source: MARINA BIOTECH, INC

Windlas Healthcare Invests $2 Million in Working Capital to Support Marina Biotech’s Manufacturing Initiatives

CITY OF INDUSTRY, Calif., Aug. 21, 2017 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB:MRNA) (OTCQB:MRNAD) (‘Marina’ or the ‘Company’) a biopharmaceutical company focused on the development and...
August 02, 2017 08:45 ET | Source: MARINA BIOTECH, INC

Marina Biotech Announces 1-for-10 Reverse Stock Split in Preparation for Proposed Up-Listing of its Common Stock to the NASDAQ Capital Market

CITY OF INDUSTRY, Calif., Aug. 02, 2017 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB:MRNA) a biopharmaceutical company focused on the development and commercialization of innovative therapeutics...
July 25, 2017 12:00 ET | Source: MARINA BIOTECH, INC

Marina Biotech Announces Binding Letter of Intent for the Sale of its DiLA2 Delivery Platform

CITY OF INDUSTRY, Calif., July 25, 2017 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB:MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics...
July 24, 2017 12:00 ET | Source: MARINA BIOTECH, INC

Marina Biotech Acquires DyrctAxess™ Technology Platform to Support Sales and Marketing of Prestalia®

CITY OF INDUSTRY, Calif., July 24, 2017 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB:MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics...
July 19, 2017 12:00 ET | Source: MARINA BIOTECH, INC

Marina Biotech Announces a License Agreement to SMARTICLES and CRN platforms for Antisense DNA therapeutics

CITY OF INDUSTRY, Calif., July 19, 2017 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB:MRNA) a biopharmaceutical company focused on the development and commercialization of innovative therapeutics...